eFFECTOR Therapeutics to Host Virtual Investor R&D Day on January 24, 2024 - eFFECTOR Therapeutics (NASDAQ:EFTR)

- Summary of development progress for tomivosertib and zotatifin and a preview of anticipated 2024 milestones- - Review of recently announced interim data from dose escalation and Phase 2 expansion cohorts of

Related Keywords

United States ,Steve Worland ,Kevin Kalinsky ,Winship Cancer Institute ,Oncology At Emory University School Of Medicine ,Department Of Hematology ,Glenn Family Breast Center ,Pfizer ,Exchange Commission ,Effector Therapeutics Inc ,Medical Oncology ,Emory University School ,Winship Cancer ,Investor Rd Day ,Private Securities Litigation Reform Act ,